Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06842472 | PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer | not yet recruiting | Phase 2 | 70 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Feb 24, 2025 | clinicaltrials |
| NCT06833216 | Familial Breast Cancer in China | not yet recruiting | — | 500 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 18, 2025 |
| clinicaltrials |
| NCT06827639 | In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients(FUTURE) | not yet recruiting | — | 640 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06825949 | A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients | not yet recruiting | N/A | 55 | Guangdong Provincial People's HospitalOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06825975 | A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients | not yet recruiting | N/A | 348 | Guangdong Provincial People's HospitalOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05821686 | Efficacy of Interleukin-2 in Triple Negative Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 10 | Nova Scotia Health AuthorityOTHER | 0 | Feb 12, 2025 | clinicaltrials |
| NCT06819501 | Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs | not yet recruiting | N/A | 226 | Guangdong Provincial People's HospitalOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06803381 | Somesthesia in Cancer Patients: Variability and Influence on Eating Experience(SOMEST'ALIM2) | not yet recruiting | — | 96 | Hospices Civils de LyonOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06811220 | The Effect of Oral Administration of Hesperidin and Diosmin in Reducing Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients | not yet recruiting | Phase 3 | 140 | Alexandria UniversityOTHER | 0 | Feb 6, 2025 | clinicaltrials |
| NCT06806072 | BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY | not yet recruiting | N/A | 96 | Parc de Salut MarOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06795503 | Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients | not yet recruiting | Phase 3 | 1,462 | Fudan UniversityOTHER | 0 | Jan 28, 2025 | clinicaltrials |
| NCT06797622 | Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer | not yet recruiting | Phase 2 | 50 | Fudan UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06792591 | Diagnostic Performance of Positron Emission Mammography in Breast Cancer | not yet recruiting | — | 54 | Assiut UniversityOTHER | 0 | Jan 24, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06779656 | Regional Anesthesia Techniques in Breast Surgery | not yet recruiting | N/A | 180 | Xiaguang DuanOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06777537 | Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer | not yet recruiting | Phase 4 | 200 | Shandong UniversityOTHER | 0 | Jan 16, 2025 | clinicaltrials |
| NCT06769919 | A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer | not yet recruiting | Phase 2 / Phase 3 | 340 | Xijing HospitalOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06217458 | The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS(CEMinDCIS) | not yet recruiting | N/A | 100 | Clinical Hospital Center RijekaOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06757335 | A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 204 | Hinova Pharmaceuticals Inc.INDUSTRY | 0 | Jan 3, 2025 | clinicaltrials |
| NCT06753357 | Breast Cancer Rehabilitation Needs and Service Uptake | not yet recruiting | — | 376 | Changi General HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06750848 | Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer | not yet recruiting | Phase 2 | 48 | Jundong WuOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT06746870 | A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer | not yet recruiting | Phase 2 | 148 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 0 | Dec 24, 2024 | clinicaltrials |
| NCT06744998 | Hemopatch Implication After Axillary Dissection for Breast Cancer(BreastPatch) | not yet recruiting | N/A | 190 | European Institute of OncologyOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT06733233 | A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer | not yet recruiting | Phase 2 | 23 | Guangzhou Women and Children's Medical CenterOTHER | 0 | Dec 13, 2024 | clinicaltrials |
| NCT06731153 | JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC | not yet recruiting | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06718335 | Pyrotinib in HER2-positive Early Breast Cancer | not yet recruiting | N/A | 156 | Nie JianyunOTHER | 0 | Dec 11, 2024 | clinicaltrials |
| NCT06729099 | Validity of Brain Metastasis Risk Predictive Model in Hormone Positive Breast Cancer Patients | not yet recruiting | — | 128 | Assiut UniversityOTHER | 0 | Dec 11, 2024 | clinicaltrials |
| NCT06723132 | A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients With Brain Metastesis | not yet recruiting | — | 60 | Assiut UniversityOTHER | 0 | Dec 9, 2024 | clinicaltrials |
| NCT06724263 | A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors | not yet recruiting | Phase 2 | 120 | Tasly Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Dec 9, 2024 | clinicaltrials |
| NCT06711549 | "Serratus Anterior Plane Block" Versus "Serratus Posterior Superior Plane Intercostal Plane Block" for Patients Undergoing Breast Surgery | not yet recruiting | N/A | 46 | Ospedale di CamposampieroOTHER | 0 | Dec 2, 2024 | clinicaltrials |
| NCT06711939 | Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)(VCV) | not yet recruiting | — | 515 | Mitera HospitalOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06706726 | To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer | not yet recruiting | N/A | 40 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Nov 29, 2024 | clinicaltrials |
| NCT06611514 | Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer(PROPOSE) | not yet recruiting | Phase 3 | 95 | European Institute of OncologyOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT06695052 | Axillary LNs Evalution in Breast Cancer by Multimodal Us | not yet recruiting | — | 30 | Assiut UniversityOTHER | 0 | Nov 19, 2024 | clinicaltrials |
| NCT06449417 | Aurora: a Human-centered Program for Breast Cancer Patients in Chile, Easing Neoadjuvant Chemotherapy's Effects(Aurora) | not yet recruiting | N/A | 30 | Pontificia Universidad Catolica de ChileOTHER | 0 | Nov 7, 2024 | clinicaltrials |
| NCT06407401 | Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer | not yet recruiting | Phase 3 | 399 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Nov 5, 2024 | clinicaltrials |
| NCT06671249 | Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery | not yet recruiting | N/A | 184 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06663748 | ARX788 in HER2-positive Metastatic Breast Cancer Patients | not yet recruiting | Phase 2 | 44 | Henan Cancer HospitalOTHER_GOV | 0 | Oct 29, 2024 | clinicaltrials |
| NCT06611306 | BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.(BEAT-Breast) | not yet recruiting | N/A | 42 | Imperial College LondonOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06625879 | The Mid-point Transverse Process to Pleura Block Versus Serratus Anterior Plane Block for Postoperative Analgesia After Modified Radical Mastectomy((SAPB) (MTPB)) | not yet recruiting | N/A | 30 | Ain Shams UniversityOTHER | 0 | Oct 3, 2024 | clinicaltrials |
| NCT06614751 | A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway | not yet recruiting | Phase 1 | 112 | Danatlas Pharmaceuticals Co., LtdINDUSTRY | 1 | Sep 27, 2024 | clinicaltrials |
| NCT06613373 | An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer | not yet recruiting | Phase 4 | 30 | Jiangsu Famous Medical Technology Co., Ltd.INDUSTRY | 0 | Sep 25, 2024 | clinicaltrials |
| NCT06575049 | Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery | not yet recruiting | — | 60 | Seoul National University HospitalOTHER | 0 | Sep 19, 2024 | clinicaltrials |
| NCT06586866 | JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases | not yet recruiting | Phase 2 | 25 | JenKem Technology Co., Ltd.INDUSTRY | 0 | Sep 19, 2024 | clinicaltrials |
| NCT06592560 | Asprosin in Breast Cancer | not yet recruiting | — | 84 | Marina Hanna Thabet GhobrialOTHER | 0 | Sep 19, 2024 | clinicaltrials |
| NCT06578286 | ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd | not yet recruiting | Phase 2 | 44 | Fudan UniversityOTHER | 0 | Aug 29, 2024 | clinicaltrials |
| NCT06578299 | Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer | not yet recruiting | Phase 4 | 100 | Fudan UniversityOTHER | 0 | Aug 29, 2024 | clinicaltrials |
| NCT06039956 | De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria | not yet recruiting | N/A | 100 | Nova Scotia Health AuthorityOTHER | 0 | Aug 22, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2025source: clinicaltrials